May 14, 2020
U.S. Centers for Medicare & Medicaid Services (CMS) Proposes Extending New Technology Add-on Payment (NTAP) Reimbursement for Portola Pharmaceuticals' Andexxa® for Third Year
Mar 16, 2020
Portola Pharmaceuticals Announces Results Demonstrating Andexxa® was Associated with Lowest Rate of Mortality in Patients with Multiple Types of Factor Xa Inhibitor-Related Bleeds
Aug 06, 2019
Portola Launches European Sales of Ondexxya® (Andexanet Alfa) with First Orders in Europe
May 03, 2019
Anticoagulants Market to be Worth US$ 40,158.4 Million by 2026, Says TMR
Dec 04, 2018
Perosphere Pharmaceuticals' Ciraparantag Research Presented at American Society of Hematology Annual Meeting
Oct 04, 2018
Aniara Diagnostica Launches Heparinassay.com Providing Specific Product Information for Quality Control (QC) Measurement of Heparin and Its Analogues
May 23, 2018
FDA Accepts Supplemental Biologics License Application (BLA) and Grants Priority Review for Prophylactic and Pediatric Use for Bio Products Laboratory's Coagadex® (Coagulation Factor X, Human) for Treatment of Hereditary Factor X Deficiency
Feb 13, 2018
GC Pharma and Lee's Pharm Enter into China Licensing Agreement to Develop and Commercialise GCC-4401C, an Investigational Anticoagulant
Nov 22, 2017
US Hemostasis Diagnostics Market 2021: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers
Nov 22, 2017
US Coagulation Testing Market 2021: Growth Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
Nov 22, 2017
UK Coagulation Testing Market 2021: Growth Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers